These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 30984705)
1. Relationship between serum procalcitonin level and chronic obstructive pulmonary disease. Borsi H; Nia EP; Mal-Amir MD; Raji H J Family Med Prim Care; 2019 Feb; 8(2):738-740. PubMed ID: 30984705 [TBL] [Abstract][Full Text] [Related]
2. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study. Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291 [TBL] [Abstract][Full Text] [Related]
3. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population. Pandey S; Garg R; Kant S; Verma A; Gaur P Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153 [TBL] [Abstract][Full Text] [Related]
4. Procalcitonin: Is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation? Pazarli AC; Koseoglu HI; Doruk S; Sahin S; Etikan I; Celikel S; Berktas B J Res Med Sci; 2012 Nov; 17(11):1047-51. PubMed ID: 23833579 [TBL] [Abstract][Full Text] [Related]
5. The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation. Gao D; Chen X; Wu H; Wei H; Wu J Exp Ther Med; 2017 Jul; 14(1):193-198. PubMed ID: 28672914 [TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444 [TBL] [Abstract][Full Text] [Related]
7. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis. Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690 [No Abstract] [Full Text] [Related]
8. The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update. Pantzaris ND; Spilioti DX; Psaromyalou A; Koniari I; Velissaris D J Clin Med Res; 2018 Jul; 10(7):545-551. PubMed ID: 29904438 [TBL] [Abstract][Full Text] [Related]
9. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Mohan M; Parthasarathi A; S K C; Biligere Siddaiah J; Mahesh PA Cureus; 2021 Aug; 13(8):e16864. PubMed ID: 34367840 [TBL] [Abstract][Full Text] [Related]
11. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Qian W; Huang GZ Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474 [TBL] [Abstract][Full Text] [Related]
13. Values of procalcitonin and C-reactive proteins in the diagnosis and treatment of chronic obstructive pulmonary disease having concomitant bacterial infection. Li Y; Xie L; Xin S; Li K Pak J Med Sci; 2017; 33(3):566-569. PubMed ID: 28811772 [TBL] [Abstract][Full Text] [Related]
14. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU. Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862 [TBL] [Abstract][Full Text] [Related]
15. Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU. Daubin C; Fournel F; Thiollière F; Daviaud F; Ramakers M; Polito A; Flocard B; Valette X; Du Cheyron D; Terzi N; Fartoukh M; Allouche S; Parienti JJ; Ann Intensive Care; 2021 Mar; 11(1):39. PubMed ID: 33675432 [TBL] [Abstract][Full Text] [Related]
16. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients]. Jiang M; Ma JF Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002 [TBL] [Abstract][Full Text] [Related]
17. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease]. Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. Hoult G; Gillespie D; Wilkinson TMA; Thomas M; Francis NA BMC Pulm Med; 2022 May; 22(1):194. PubMed ID: 35549921 [TBL] [Abstract][Full Text] [Related]
19. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease. Lin TL; Chen WW; Ding ZR; Wei SC; Huang ML; Li CH J Clin Lab Anal; 2019 May; 33(4):e22831. PubMed ID: 30666727 [TBL] [Abstract][Full Text] [Related]
20. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy. Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]